WHO grants EUL for Covovax
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
Authorized booster increases Omicron neutralizing antibody levels approximately 37-fold
The company is now ready to offer clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours
Medical footprint expansion with deeper medical grade skin contact material science expertise
Effectiveness of Covaxin against the Omicron variant is currently being studied
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales
Collaboration aims to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology
Subscribe To Our Newsletter & Stay Updated